Company File · BSE 539871 · Latest filing Q1 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Thyrocare Technologies Limited
Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27
ISIN INE594H01019 · THYROCARE · Healthcare › Healthcare Services
Price & valuation · BSE close, 19 Oct 2026
Below its usual level
- Sales growth
- +24.3%
- Profit growth
- +34.1%
- Op. margin
- 32.2%
- P/E
- 42.7×
- Usual P/E
- 51.5×
- Price/book
- 12.8×
- ROCE
- 37.8%
- ROE
- 28.7%
- Debt/equity
- 0.00×
- Promoter
- 51.02%
- Pledged
- 0.00%
Earnings callsNo earnings-call transcript from Thyrocare Technologies in our data yet. When it files one on BSE, the call notes appear here within a few hours. See its call page
Is it expensive, and is it a good business?
Key ratios
In short Priced below its own usual level (P/E 42.7× vs 51.5×), earns high returns on capital (ROCE 37.8%) and has no debt.
What you pay Valuation
Buyers pay about ₹43 for every ₹1 the company earned per share over the last year. Below its 1-year median of 51.5×.
Latest BSE close ÷ last four quarters' basic EPS. Earlier quarters' EPS is restated on the latest share count after a split or bonus. As of 19th October 2026.
The share price is 12.8 times the accounting value of each share. Below its 1-year median of 14.3×.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
The market values the company at 8.6 times its yearly sales.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
The whole business (shares plus debt, minus cash) is valued at about 26.4 years of its operating profit.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
The P/E of 42.7 divided by EPS growth of 79.4% (the latest financial year vs the year before). Below 1 is often read as cheap for the growth; above 2 as expensive.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid ₹9.33 a share in the last 12 months (2 payouts), 1.98% of today's share price.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Each ₹100 of shareholders' money and debt earned about ₹37.8 before interest & tax.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.
For every ₹100 of shareholders' money, the company earned about ₹28.7 in a year.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.
Needs reported tax expense that reconciles with profit; not yet available for these periods.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.
Every ₹1 of assets generated about ₹1.15 of sales in a year.
Last 12 months' revenue ÷ average total assets. As of 31st March 2026.
Operating profit covered interest costs about 69 times.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.
The company reported no borrowings.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.
Who owns it Ownership & more
The founders or parent group own 51.02% of the company.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th September 2026.
Promoter holding fell by 9.90 percentage points last quarter.
Latest quarter's promoter holding minus the previous quarter's. As of 30th September 2026.
Promoter holding, quarter by quarter
- Sep 202651.02%
- Jun 202660.92%
- Mar 202660.92%
- Dec 202560.93%
Promoters reported no pledged shares.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th September 2026.
Pledged, quarter by quarter
- Sep 20260.00%
- Jun 2026100.00%
- Mar 2026100.00%
- Dec 2025100.00%
After paying for new plant & equipment, operations left ₹192 crore of cash.
Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.
Free cash flow, year by year
- FY26₹192 Cr
- FY25₹146 Cr
Each share has a face (nominal) value of ₹10. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 15.92 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹7,501 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹7,433 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
The company reported ₹176 crore of profit over the last four quarters.
Sum of the last four quarters' reported profit after tax. As of 30th June 2026.
Each share earned about ₹11.05 over the last year.
Sum of the last four quarters' basic EPS. Earlier quarters' EPS is restated on the latest share count after a split or bonus. As of 30th June 2026.
Each share is backed by about ₹37 of net assets on the books.
Shareholders' equity ÷ shares. As of 31st March 2026.
About ₹32.1 of every ₹100 of sales was left after running costs.
EBITDA ÷ revenue over the last four quarters. As of 30th June 2026.
About ₹21.4 of every ₹100 of sales became profit last quarter.
Profit after tax ÷ revenue for the latest quarter. As of 30th June 2026.
Sales were 24.3% higher than a year earlier.
Latest quarter's revenue vs the same quarter last year. As of 30th June 2026.
Profit was 34.1% higher than a year earlier.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th June 2026.
Short-term assets cover short-term bills 3.39 times.
Current assets ÷ current liabilities. As of 31st March 2026.
Customers take about 33 days to pay.
Trade receivables ÷ last 12 months' revenue × 365. As of 31st March 2026.
Stock on hand equals about 21 days of sales.
Inventories ÷ last 12 months' revenue × 365. As of 31st March 2026.
7.2% of pre-tax profit came from other income (interest, dividends, gains).
Other income ÷ profit before tax, last 12 months. As of 30th June 2026.
Each ₹1 of profit brought in ₹1.31 of operating cash.
Latest full year's cash from operations ÷ profit after tax. As of 31st March 2026.
Cash exceeds borrowings by ₹68 crore.
Cash & bank balances − borrowings. As of 31st March 2026.
Needs reported tax expense that reconciles.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th June 2026.
Everything the company owns earned 22.6% in a year.
Last 12 months' profit ÷ average total assets. As of 31st March 2026.
Operating profit before interest, depreciation & tax was ₹282 crore.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th June 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
The company spent ₹21 crore on plant & equipment.
Purchase of property, plant & equipment, latest full year. As of 31st March 2026.
No borrowings reported.
Current + non-current borrowings. As of 31st March 2026.
Foreign institutions own 9.37%.
Foreign institutional holding from the latest shareholding pattern. As of 30th September 2026.
Domestic institutions own 25.92%.
Domestic institutional holding (mutual funds, insurers, banks, pension funds). As of 30th September 2026.
The highest price in the last year was ₹662.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 12th August 2026.
The lowest price in the last year was ₹342.55.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 23rd March 2026.
The share price moved 14.0% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
About 84% of the last year's earnings per share was paid out as dividends.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th June 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 15.92 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 4 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 216.5 | 195.5 | 224.0 | 240.0 |
| EBITDA | 71.4 | 57.8 | 75.1 | 77.3 |
| Operating margin | 33.0% | 29.6% | 33.5% | 32.2% |
| One-off items | – | −6.2 | – | – |
| Profit after tax | 47.8 | 28.1 | 48.7 | 51.3 |
| Profit after tax without one-offs | 47.8 | 32.7 | 48.7 | 51.3 |
| Basic EPS (₹) | 9.05 | 1.82 | 2.99 | 3.23 |
One-off items: exceptional items reported separately in the filing. Profit without one-offs takes them out after tax at 25%.
Latest filings BSE
Corporate announcements 9
- 28 Sep 2026Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- 24 Sep 2026Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.
- 21 Sep 2026Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary), Subject To The Approval Of The Shareholders Of The Company
Quarterly results 0
None in the filings we hold.
Conference calls 0
None in the filings we hold.
Investor presentations 0
None in the filings we hold.
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.